BioNTech SE (BNTX) Operating Expenses (2018 - 2026)

BioNTech SE has reported Operating Expenses for 8 years, with the latest figure at -$784.6 million in Q4 2025.

• Quarterly Operating Expenses fell 1.61% year-over-year to -$784.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 billion (up 1.74% YoY) and the FY2025 annual result came in at $3.0 billion, down 0.57% from the prior year.
• Operating Expenses grew to -$784.6 million in Q4 2025 per BNTX's latest filing, from -$802.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at -$299.7 million in Q2 2021 and troughed at -$813.6 million in Q2 2024.
• A 5-year average of -$600.6 million and a median of -$653.9 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2021 and 2025: Operating Expenses sank 131816999.25% in 2021, then increased 12.79% in 2025.
• Over 5 years, Operating Expenses stood at -$460.3 million in 2021, then slumped by 39.56% to -$642.4 million in 2022, then fell by 17.58% to -$755.4 million in 2023, then dropped by 2.22% to -$772.2 million in 2024, then decreased by 1.61% to -$784.6 million in 2025.
• According to Business Quant data, Operating Expenses over the past three periods registered -$784.6 million, -$802.0 million, and -$709.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.